cdifffoundation.org
Pfizer’s C.difficile Vaccine Candidate PF-06425090 Will Progress Into Phase 3 Study
Pfizer Announces Positive Top-Line Results from Phase 2 Study of Investigational Clostridium difficile Vaccine for the Prevention of C. difficile Infection Pfizer’s C. difficile Vaccine Candidate t…